Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.370
+0.040 (1.20%)
At close: Jan 17, 2025, 4:00 PM
3.300
-0.070 (-2.08%)
After-hours: Jan 17, 2025, 5:30 PM EST
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $284.64 million as of January 17, 2025. Its market cap has increased by 7.96% in one year.
Market Cap
284.64M
Enterprise Value
-196.34M
1-Year Change
7.96%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $284.64M, a decrease of -85.31%. That is a compound annual growth rate of -36.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 284.64M | 0.60% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |